BLACK DIAMOND THERAPEUTICS I

Black Diamond Therapeutics (BDTX) trades at $2.08, 5% YTD gain, 24‑hr volume $4.9 m. Find the latest price, market cap, and 52‑week range.

Black Diamond Therapeutics (BDTX) posts modest 0.48% rise to $2.09, a small‑cap biotech eyeing genetic‑cancer therapies; monitor its clinical milestones amid market volatility.

Black Diamond Therapeutics (BDTX) shows strong upside with near 52‑week highs, disciplined trading, and phase‑II trial milestones—an attractive biotech pick.